Taichi for Overweight/Obese Adolescent and Young Women With Polycystic Ovary Syndrome (PCOS)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02608554|
Recruitment Status : Active, not recruiting
First Posted : November 18, 2015
Last Update Posted : December 26, 2019
|Condition or disease||Intervention/treatment||Phase|
|Polycystic Ovary Syndrome||Behavioral: Taichi Behavioral: Self-monitored exercise||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||50 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Taichi for Treating Overweight/Obese Adolescent and Young Women With Polycystic Ovary Syndrome (PCOS)|
|Actual Study Start Date :||October 2016|
|Estimated Primary Completion Date :||December 31, 2019|
|Estimated Study Completion Date :||March 31, 2020|
The 24 forms of simplified TCC recommended as the popular health sport by the General Administration of Sport of China were applied.
The program of Taichi training consisted of 60 minutes exercise sessions, 3 days per week for 12 weeks, based on their original level of physical activity. Each session comprised 40 minutes of Taichi training plus a 10-minute warm-up and cool-down. The Taichi training was instructed by the same experienced Taichi instructors who were qualified in the teaching of Taichi. The 24 forms of simplified Taichi recommended as the popular health sport by the General Administration of Sport of China were applied.
Active Comparator: Self-monitored exercise
Exercise was self-monitored and consisted of brisk walking, cycling, jogging, or any other aerobic exercise.
Behavioral: Self-monitored exercise
Exercise was self-monitored and consisted of brisk walking, cycling, jogging, or any other aerobic exercise for 60 mins. 3 days per week for 12 weeks.
- Body mass index (BMI) [ Time Frame: 3 months ]
- Fasting plasma glucose (Glu) [ Time Frame: 3 months ]
- Fasting insulin (Ins) [ Time Frame: 3 months ]
- HOMA-IR [ Time Frame: 3 months ]HOMA-IR = fasting insulin concentrations (mIU/L) ×fasting plasma glucose concentrations (mmol/L)/22.5
- Testosterone (T) [ Time Frame: 3 months ]
- Luteinizing hormone (LH) [ Time Frame: 3 months ]
- Follicle stimulating hormone (FSH) [ Time Frame: 3 months ]
- Waist/hip ratio [ Time Frame: 3 months ]
- Ferriman-Gallwey score [ Time Frame: 3 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02608554
|First Affiliated Hospital, Heilongjiang University of Chinese Medicine|
|Harbin, Heilongjiang, China, 150040|
|Study Chair:||Lihui Hou, Bachelor||First Affiliated Hospital of Heilongjiang University Of Chinese|